Organigram to Report First Quarter Fiscal 2022 Results on January 11, 2022
January 05 2022 - 6:00AM
Business Wire
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent
company of Organigram Inc. (together, the “Company” or
“Organigram”), a leading licensed producer of cannabis, announced
today it will report earnings results for its first quarter fiscal
2022 ended November 30, 2021 on Tuesday, January 11, 2022 before
market open.
The Company will host a conference call to discuss its results
with details as follows:
Date: January 11, 2022 Time: 8:00 am Eastern Time
To register for the conference call, please use this link:
http://www.directeventreg.com/registration/event/7385048
To ensure you are connected for the full call, we suggest
registering a day in advance or at minimum 10 minutes before the
start of the call. After registering, a confirmation will be sent
through email, including dial in details and unique conference call
codes for entry. Registration is open through the live call.
To access the webcast:
https://event.on24.com/wcc/r/3574376/4E62A1D28ADF780D54B2E4FE4F5760FD
A replay of the webcast will be available within 24 hours after
the conclusion of the call at https://www.organigram.ca/investors
and will be archived for a period of 90 days following the
call.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and
TSX listed company whose wholly-owned subsidiaries include:
Organigram Inc. and Laurentian Organic Inc., licensed producers of
cannabis and cannabis-derived products in Canada, and The Edibles
and Infusions Corporation, a licensed manufacturer of
cannabis-infused soft chews and candy in Canada.
Organigram is focused on producing high-quality, indoor-grown
cannabis for patients and adult recreational consumers in Canada,
as well as developing international business partnerships to extend
the Company’s global footprint. Organigram has also developed a
portfolio of legal adult-use recreational cannabis brands,
including The Edison Cannabis Company, Indi, Bag o’ Buds, SHRED and
Trailblazer. Organigram operates facilities in Moncton, New
Brunswick and Lac-Supérieur, Quebec, with a dedicated manufacturing
facility in Winnipeg, Manitoba. The Company is regulated by the
Cannabis Act and the Cannabis Regulations (Canada).
This news release contains forward-looking information.
Forward-looking information, in general, can be identified by the
use of forward-looking terminology such as “outlook”, “objective”,
“may”, “will”, “could”, “would”, “might”, “expect”, “intend”,
“estimate”, “anticipate”, “believe”, “plan”, “continue”, “budget”,
“schedule” or “forecast” or similar expressions suggesting future
outcomes or events. They include, but are not limited to,
statements with respect to expectations, projections or other
characterizations of future events or circumstances, and the
Company’s objectives, goals, strategies, beliefs, intentions,
plans, estimates, forecasts, projections and outlook, including
statements relating to = timing for announcement of results. These
statements are not historical facts but instead represent
management beliefs regarding future events, many of which, by their
nature are inherently uncertain and beyond management control.
Forward-looking information has been based on the Company’s current
expectations about future events.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220105005348/en/
For Investor Relations enquiries:
investors@organigram.ca
For Media enquiries: Megan McCrae Senior Vice-President,
Marketing and Communications megan.mccrae@organigram.ca
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Sep 2023 to Sep 2024